Agility for multiple viruses

Adaptive Phage Therapeutics (APT) is developing PhageBank, a collection of viruses to kill antibiotic-resistant superbugs. They needed a highly agile vial filling system and chose the Microcell™ Vial Filler to accelerate the process of filling multiple viruses every day to build a library of 1000+ drug products.

Gloveless operation of the Microcell Vial Filler

Resources

Customer story: Amgen

Amgen’s assessment of the SA25 Aseptic Filling Workcell as a next-generation filling system.

Customer story: Emergent BioSolutions

How Emergent BioSolutions transitioned their commercial products to our gloveless filling platform.

Customer story: WuXi Biologics

This CDMO reached its first GMP batch release 15 months after purchasing a workcell from Cytiva.

Closed robotic workcells

Learn how they differ from conventional systems and how your drug product operations can benefit.

For clinical trials and product development

Moderna is using an SA25 Aseptic Filling Workcell from Cytiva at its Norwood, Massachusetts site for both clinical trial supply manufacturing and product development.

Cytiva SA25 Aseptic Filling Workcell installed in a pharmaceutical cleanroom

Gaining control for gene-edited therapies

Locus Biosciences is taking the fight against antibiotic-resistant bacteria using CRISPR-Cas3 gene-edited therapies. They chose the Microcell™ Vial Filler to gain control over their processes.